Global Leadless Pacemaker market - 2024-2031
Global Leadless Pacemaker market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
A leadless pacemaker is a medical device that is implanted right inside the heart without the implantation of leads in the heart or a separate battery under the heart. It comes with a lot of advantages when compared to conventional pacemakers such as reduced infection risk at the site, lead dislodgment, and blood clots.
Market Dynamics: Drivers & Restraints
Increasing Market Developments
Pacemaker systems have undergone rapid advancements such as increased battery life, reduced generator size, and other improvements that increased the efficiency of leadless pacemakers. Advancements in battery technologies, and the development of sophisticated devices.
In July 2021, MicroPort, Cardiac Rhythm Management Limited (a subsidiary of Cardiac invested US$150 Million in the development of implantable devices and defibrillators. In addition, MicroPort CRM is currently developing a sub-cutaneous ICD (S-ICD) and a leadless pacemaker. In April 2022, Cairdac raised $18.5M in funding for developing a leadless pacemaker transcatheter system (ALPS) powered entirely using kinetic energy from the heart.
High incidence of battery malfunction
Failure of the device can be seen due to the battery malfunction. For instance, according to AHA journals organization, 2023, there was a high incidence of battery failure of the Nanostim LCP in a long time. More than 40% of devices failed after 3 years. Pacemaker battery depletion occurs due to inadequate follow-up procedures. Leadless pacemakers fail to integrate with defibrillator systems.
Segment Analysisn
The global leadless pacemaker market is segmented based on type, product, application end-user and region.
Dual-chamber type is Expected to Dominate the Market
A dual-chamber leadless pacemaker is used for a wider range of treatment options as it consists of 2 devices. An increase in approvals by the FDA is expected to drive the market in the forecast period. For instance, in May 2023, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.
In July 2023, Abbott received the U.S. Food and Drug Administration (FDA) approval for the AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.
In January 2022, Medtronic plc received regulatory approval from Japan's Ministry of Health, Labor, and Welfare for the sale and reimbursement of the Micra AV Transcatheter Pacing System (TPS).
Geographical Analysis
North America is Expected to Dominate the Global Market
North America is expected to hold the largest share of the market due to the increase in cardiovascular diseases in the US and Canada. For instance, according to the American Heart Association, 2024, heart disease has been a leading cause of death for the past 100 years. Approximately, 46.7% of U.S. adults have high blood pressure. Yet, over 38% of those with high blood pressure are unaware that they have it.
Furthermore, according to the Journal of Cardiac Failure, approximately 6.7 million Americans over 20 years of age have poor heart, and the prevalence of cardiac failure is expected to rise to 8.5 million Americans by 2030.
Market Segmentation
By Type
• Single Chamber
• Dual Chamber
By Product
• Micra Transcatheter Pacing System
• Nanostim Leadless Pacemaker
• Others
By Application
• Atrial Fibrillation
• Sinus Node Dysfunction
• Bradycardia-tachycardia syndrome
• Others
By End User
• Hospital Pharmacies
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Outpatient Facilities
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In February 2022, Abbott released the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study.
Competitive Landscape
The major global players in the leadless pacemaker market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, EBR Systems, Inc, Biotronik, CAIRDAC, Lepu Medical Technology (Beijing)Co., Ltd., Nanostim Inc among others.
Why Purchase the Report?
• To visualize the global leadless pacemaker market segmentation based on type, product, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of leadless pacemaker market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global leadless pacemaker market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Type
- 3.2. Snippet by Product
- 3.3. Snippet by Application
- 3.4. Snippet by End User
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing Market Developments
- 4.1.1.2. YY
- 4.1.2. Restraints
- 4.1.2.1. High incidence of battery malfunction
- 4.1.2.2. YY
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Reimbursement Analysis
- 5.6. Patent Analysis
- 5.7. Pipeline Analysis
- 5.8. Epidemiology
- 5.9. SWOT Analysis
- 5.10. DMI Opinion
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
- 7.2. Single Chamber*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Dual Chamber
- 8. By Product
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 8.1.2. Market Attractiveness Index, By Product
- 8.2. Micra Transcatheter Pacing System*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Nanostim Leadless Pacemaker
- 8.4. Others
- 9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
- 9.2. Atrial Fibrillation*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Sinus Node Dysfunction
- 9.4. Bradycardia-tachycardia syndrome
- 9.5. Others
- 10. By End User
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
- 10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Cardiac Centers
- 10.4. Ambulatory Surgical Centers
- 10.5. Outpatient Facilities
- 10.6. Others
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. UK
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia-Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Medtronic Plc*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
- 13.2. Abbott Laboratories
- 13.3. Boston Scientific Corporation
- 13.4. MicroPort Scientific Corporation
- 13.5. EBR Systems, Inc
- 13.6. Biotronik
- 13.7. CAIRDAC
- 13.8. Lepu Medical Technology (Beijing)Co., Ltd.
- 13.9. Nanostim Inc
- LIST NOT EXHAUSTIVE
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook